INNOVAGE HOLDING CORP (INNV) Stock Fundamental Analysis
USA - NASDAQ:INNV - US45784A1043 - Common Stock
5.04 USD
+0.2 (+4.13%)
Taking everything into account, INNV scores 3 out of 10 in our fundamental rating. INNV was compared to 100 industry peers in the Health Care Providers & Services industry. The financial health of INNV is average, but there are quite some concerns on its profitability. INNV has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year INNV has reported negative net income.
INNV had a positive operating cash flow in the past year.
INNV had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: INNV reported negative operating cash flow in multiple years.
1.2 Ratios
INNV has a Return On Assets of -5.75%. This is in the lower half of the industry: INNV underperforms 69.00% of its industry peers.
INNV's Return On Equity of -12.90% is on the low side compared to the rest of the industry. INNV is outperformed by 61.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.75% | ||
| ROE | -12.9% | ||
| ROIC | N/A |
ROA(3y)-5.61%
ROA(5y)-5.25%
ROE(3y)-11.52%
ROE(5y)-9.93%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 18.00%, INNV is doing worse than 64.00% of the companies in the same industry.
INNV's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for INNV so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 18% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.44%
GM growth 5Y-6.3%
2. Health
2.1 Basic Checks
INNV does not have a ROIC to compare to the WACC, probably because it is not profitable.
INNV has less shares outstanding than it did 1 year ago.
The number of shares outstanding for INNV has been increased compared to 5 years ago.
Compared to 1 year ago, INNV has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.63 indicates that INNV is not a great score, but indicates only limited risk for bankruptcy at the moment.
INNV has a Altman-Z score (2.63) which is in line with its industry peers.
INNV has a debt to FCF ratio of 2.72. This is a good value and a sign of high solvency as INNV would need 2.72 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.72, INNV is in the better half of the industry, outperforming 78.00% of the companies in the same industry.
A Debt/Equity ratio of 0.28 indicates that INNV is not too dependend on debt financing.
INNV's Debt to Equity ratio of 0.28 is fine compared to the rest of the industry. INNV outperforms 67.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 2.72 | ||
| Altman-Z | 2.63 |
ROIC/WACCN/A
WACC9.11%
2.3 Liquidity
INNV has a Current Ratio of 1.07. This is a normal value and indicates that INNV is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.07, INNV is doing worse than 68.00% of the companies in the same industry.
INNV has a Quick Ratio of 1.07. This is a normal value and indicates that INNV is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.07, INNV is doing worse than 64.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.07 |
3. Growth
3.1 Past
INNV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.00%, which is quite impressive.
The Revenue has grown by 11.76% in the past year. This is quite good.
INNV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.52% yearly.
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)11.76%
Revenue growth 3Y6.91%
Revenue growth 5Y8.52%
Sales Q2Q%15.1%
3.2 Future
INNV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 77.26% yearly.
INNV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.21% yearly.
EPS Next Y195.62%
EPS Next 2Y101.79%
EPS Next 3Y77.26%
EPS Next 5YN/A
Revenue Next Year8.7%
Revenue Next 2Y9.18%
Revenue Next 3Y9.21%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for INNV. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 15.20 indicates a correct valuation of INNV.
INNV's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. INNV is cheaper than 76.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.27. INNV is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 15.2 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INNV indicates a slightly more expensive valuation: INNV is more expensive than 66.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INNV is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.7 | ||
| EV/EBITDA | 172.75 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INNV's earnings are expected to grow with 77.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y101.79%
EPS Next 3Y77.26%
5. Dividend
5.1 Amount
INNV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:INNV (11/5/2025, 10:44:05 AM)
5.04
+0.2 (+4.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners12.08%
Inst Owner Change0.04%
Ins Owners1.96%
Ins Owner Change0.38%
Market Cap683.63M
Revenue(TTM)853.70M
Net Income(TTM)-30313000
Analysts45
Price Target6.12 (21.43%)
Short Float %1.4%
Short Ratio5.76
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-234.74%
Min EPS beat(2)-527.45%
Max EPS beat(2)57.98%
EPS beat(4)1
Avg EPS beat(4)-191.55%
Min EPS beat(4)-527.45%
Max EPS beat(4)57.98%
EPS beat(8)3
Avg EPS beat(8)-94.7%
EPS beat(12)4
Avg EPS beat(12)-88.87%
EPS beat(16)5
Avg EPS beat(16)-94.86%
Revenue beat(2)0
Avg Revenue beat(2)-0.67%
Min Revenue beat(2)-1.24%
Max Revenue beat(2)-0.1%
Revenue beat(4)0
Avg Revenue beat(4)-1.25%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)-0.1%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)5
Avg Revenue beat(16)-0.81%
PT rev (1m)2.86%
PT rev (3m)5.88%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)150%
EPS NY rev (1m)20%
EPS NY rev (3m)200%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.87%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-1.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 15.2 | ||
| P/S | 0.8 | ||
| P/FCF | 25.7 | ||
| P/OCF | 20.8 | ||
| P/B | 2.91 | ||
| P/tB | 7.68 | ||
| EV/EBITDA | 172.75 |
EPS(TTM)-0.06
EYN/A
EPS(NY)0.33
Fwd EY6.58%
FCF(TTM)0.2
FCFY3.89%
OCF(TTM)0.24
OCFY4.81%
SpS6.29
BVpS1.73
TBVpS0.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.75% | ||
| ROE | -12.9% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 18% | ||
| FCFM | 3.12% |
ROA(3y)-5.61%
ROA(5y)-5.25%
ROE(3y)-11.52%
ROE(5y)-9.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.44%
GM growth 5Y-6.3%
F-Score6
Asset Turnover1.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 2.72 | ||
| Debt/EBITDA | 19.32 | ||
| Cap/Depr | 32.1% | ||
| Cap/Sales | 0.73% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 976.7% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.07 | ||
| Altman-Z | 2.63 |
F-Score6
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)75.1%
Cap/Depr(5y)131.8%
Cap/Sales(3y)1.72%
Cap/Sales(5y)2.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
EPS Next Y195.62%
EPS Next 2Y101.79%
EPS Next 3Y77.26%
EPS Next 5YN/A
Revenue 1Y (TTM)11.76%
Revenue growth 3Y6.91%
Revenue growth 5Y8.52%
Sales Q2Q%15.1%
Revenue Next Year8.7%
Revenue Next 2Y9.18%
Revenue Next 3Y9.21%
Revenue Next 5YN/A
EBIT growth 1Y30.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year295.43%
EBIT Next 3Y71.46%
EBIT Next 5YN/A
FCF growth 1Y159.37%
FCF growth 3YN/A
FCF growth 5Y-3.62%
OCF growth 1Y189.07%
OCF growth 3Y6.38%
OCF growth 5Y-5.59%
INNOVAGE HOLDING CORP / INNV FAQ
Can you provide the ChartMill fundamental rating for INNOVAGE HOLDING CORP?
ChartMill assigns a fundamental rating of 3 / 10 to INNV.
Can you provide the valuation status for INNOVAGE HOLDING CORP?
ChartMill assigns a valuation rating of 3 / 10 to INNOVAGE HOLDING CORP (INNV). This can be considered as Overvalued.
What is the profitability of INNV stock?
INNOVAGE HOLDING CORP (INNV) has a profitability rating of 1 / 10.